Simcere Pharmaceutical Group Limited (2096)
2096 · Health Care ·
China
Simcere Pharmaceutical Group Limited (2096) is a company in the Health Care sector, based in China. The stock is held in 3 ETFs we track – with its largest weight of 0.01 % in IS3N (msci-em-imi). Anyone holding one of these ETFs also owns a small indirect stake in Simcere Pharmaceutical Group Limited.
How many funds hold this stock?
Below-average ETF coverage: 3 of the 95 ETFs we cover hold Simcere Pharmaceutical Group Limited, spread across 2 indices. That puts the stock in more ETFs than 23.2 % of the 4,334 stocks we cover.
The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.
What ETF is Simcere Pharmaceutical Group Limited in?
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| IS3N | msci-em-imi | 0.01 % | €0.10 |
| SPYI / SPSA | msci-acwi-imi | 0.00 % | €0.00 |
The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Simcere Pharmaceutical Group Limited as of the fund's latest holdings list.
Weight in IS3N since 2024
In IS3N, a fund tracking the MSCI EM IMI, Simcere Pharmaceutical Group Limited had a weight of 0.01 % on Mar 29, 2024 and 0.01 % on Sep 18, 2026. Its share peaked at 0.01 % on Mar 29, 2024. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.
How much Simcere Pharmaceutical Group Limited overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Simcere Pharmaceutical Group Limited — the figure counts the ETFs holding both.
| Stock | Ticker | Shared ETFs | r |
|---|---|---|---|
| HUTCHMED (China) Limited | 13 | 3 | – |
| Ascletis Pharma Inc. | 1672 | 3 | – |
| Consun Pharmaceutical Group Ltd. | 1681 | 3 | – |
| AK Medical Holdings Ltd. | 1789 | 3 | – |
| Everest Medicines Ltd. | 1952 | 3 | – |
| Lepu Biopharma Co. Ltd. Class H | 2157 | 3 | – |
| Yidu Tech Inc. | 2158 | 3 | – |
| Keymed Biosciences Inc. | 2162 | 3 | – |


